Secure Your Investment: Top Investor Counsel Urges SCYNEXIS Inc. Shareholders to Take Action Before Securities Class Action Deadline

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages SCYNEXIS, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action NEW YORK, Nov. 24, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of SCYNEXIS, Inc. (NASDAQ: SCYX) between March 31, 2023 and September 22, 2023, both…

Read More

Act Now: Protect Your Investment with AXSM Before the December 7th Deadline – A Reminder from Rosen, a Top Law Firm

AXSM FINAL DEADLINE ALERT Rosen Law Firm Reminds Investors Nov. 24, 2023 (GLOBE NEWSWIRE) Rosen Law Firm, a global investor rights law firm, is reminding investors of the common stock of Axsome Therapeutics, Inc. (“Axsome”) (NASDAQ: AXSM) of the reopening of the lead plaintiff appointment process in a class action lawsuit against Axsome and certain…

Read More

Attention Barclays PLC Investors: Don’t Miss Out on Important Deadline for Securities Class Action – BCS Notice from Rosen, the First Filing Firm!

Welcome Back, Securities Savvy Readers! Have you ever invested in Barclays PLC securities between July 22, 2019, and October 12, 2023? If so, listen up because we have some important news for you. The Rosen Law Firm, a powerhouse in global investor rights, has a reminder for all purchasers of BCS and BCLYF stocks during…

Read More

Breaking News: Celularity Inc. Receives Nasdaq Notice for Delayed Form 10-Q Filing

Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing Overview On November 24, 2023, Celularity Inc. (Nasdaq: CELU) disclosed that they had received a notification from the Nasdaq Stock Market LLC regarding a late Form 10-Q filing. The company, known for its development of allogeneic cell therapies and biomaterial products, shared the…

Read More

Gain Therapeutics: Celebrating the Successful Closing of $10.1 Million Public Offering and Private Placement of Common Stock and Warrants, Including Full Exercise of Over-Allotment Option

The Exciting News from Gain Therapeutics, Inc. A New Chapter in the Company’s Growth November 24, 2023 Today, Gain Therapeutics, Inc. has made a significant announcement that marks a new chapter in its growth and development. The company has successfully closed an underwritten public offering, raising a total of $10.1 million through the sale of…

Read More

Univest Securities LLC Successfully Closes $6 Million IPO for Client Elevai Labs Inc. on NASDAQ: ELAB

Univest Securities, LLC Announces Closing of $6 Million Initial Public Offering of Common Stock for its Client ELEVAI Labs Inc. (Nasdaq: ELAB) New York, Nov. 24, 2023 (GLOBE NEWSWIRE) — Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced…

Read More

Attention Investors: Don’t Miss Out on This Legal Lifesaver for FMC Corporation! Act Fast Before the Securities Class Action Deadline with Help from Rosen, the Law Firm Extraordinaire

Welcome to the Strange and Wonderful World of Securities Class Action Lawsuits By: Your Favorite Financial Wizard Hey there, fellow finance fanatics! Have you ever found yourself bored on a Friday night, scrolling through the latest business news, and stumbling upon a headline that reads: “ROSEN, A LEADING LAW FIRM, Encourages FMC Corporation Investors with…

Read More